ArticleAnnals of gastroenterological surgery2026
Perioperative and Oncological Outcomes of Colorectal Cancer Surgery in Obese Patients: A Multicenter Retrospective Study.
Article in Annals of gastroenterological surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
28 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: With global rising rates of obesity, surgeries for colorectal cancer (CRC) in obese patients are increasingly common. Although obesity may complicate surgical procedures and oncologically unbeneficial, its true clinical impact remains unclear. Methods: Patients with stage I-IV CRC who underwent surgical resection between 2017 and 2019 were enrolled from a prefecture-wide multicenter database. Patients were categorized based on body mass index (BMI) into non-obesity (BMI < 25 kg/m Results: Among 2905 patients, 2283 were non-obesity, 576 mild-obesity, and 91 severe-obesity. Younger, more often male, and had higher American Society of Anesthesiologists (ASA) class and Charlson Comorbidity Index scores are included in obesity group. Operative time and blood loss increased with BMI, while the number of retrieved lymph nodes and D3 dissection rates declined. Postoperative complications and hospital stay showed no significant differences. While recurrence-free survival (RFS) and overall survival (OS) were comparable across BMI groups, obese patients had a higher proportion of LODDS ≥ -0.7. In stage III patients, LODDS ≥ -0.7 was more strongly associated with recurrence and poor prognosis in the obese subgroup. Conclusions: Obesity is associated with increased surgical complexity and limited pathological lymph node evaluation. Among stage III CRC patients, impaired nodal stratification-as reflected by elevated LODDS-may contribute to poorer prognosis in the obese population, highlighting the need for tailored oncological strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.